secwatch.observer — SEC 8-K summary
======================================

Issuer:     SAFEGUARD SCIENTIFICS INC (SFES)
CIK:        0000086115
Form:       8-K
Filed at:   2021-08-12T23:59:59+00:00
Accession:  0001437749-21-019698
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Safeguard Scientifics Q2 net loss narrows to $0.3M; expects $43M from Flashtalking sale
--------------------------------------------------------------------------------

- Net loss of $0.3M ($0.02 per share) vs loss of $9.9M ($0.48) in Q2 2020; improvement driven by $9.2M in gains.
- Receives $3.4M cash from Velano Vascular sale, recording a $1.8M gain; no new deployments in Q2.
- Bright Health IPO converted preferred equity to 1,322,484 shares valued at $22.7M (June 30); value fell to ~$11M by Aug 10.
- Flashtalking signs definitive agreement to be acquired by Mediaocean; Safeguard expects ~$43M cash in Q3 2021.
- Carrying value of ownership interests $60.1M (cost $173.5M); recorded $2.5M impairment on other interests.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/86115/000143774921019698/0001437749-21-019698-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/86115/000143774921019698/sfe20210811_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-21-019698

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer